Five insights:
1. Net loss for the fiscal second quarter was $5.1 million, up from a net loss of $800,000 in the same period the prior year.
2. Total operating expenses increased 125.8 percent to $18.1 million, compared to the same period last year.
3. Misonix attributed $8.3 million of the operating expenses to the acquisition of Solsys Medical.
4. The Solsys Medical acquisition contributed to a 94 percent increase in product revenue for the fiscal second quarter to $19.7 million.
5. Misonix plans to broaden the scope of Nexus, its ultrasonic surgical platform, in the second half of fiscal 2020.
More articles on devices:
How will total disc replacement develop in spine? 9 spine surgeons share insights
DMC loses appeal to keep neurosurgical residency: 4 details
Neurologist found guilty in $150M fraud scheme alongside 3 other physicians
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.